2024
Effect of Filtered Blood Return on Outcomes of Pulmonary Aspiration Thrombectomy
Bitar R, Bozal S, Sisti A, Mojibian H, Marino A, Cornman-Homonoff J. Effect of Filtered Blood Return on Outcomes of Pulmonary Aspiration Thrombectomy. Journal Of Vascular And Interventional Radiology 2024, 35: 1447-1456. PMID: 38950819, DOI: 10.1016/j.jvir.2024.06.026.Peer-Reviewed Original ResearchPulmonary artery pressureAspiration thrombectomyPulmonary embolismArterial pressureDuration of intensive care unitSeverity of adverse eventsLength of hospital stayHigh-risk PEProcedure-related complicationsAdverse event ratesIntensive care unitMarker of procedural successFluoroscopy timeTransfusion requirementsBlood lossNo significant differenceTransfusion needsHospital stayPost-procedureProcedural successAdverse eventsSurrogate markerLaboratory valuesProcedural outcomesProcedural details
2023
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS
Frumm S, Shimony S, Stone R, DeAngelo D, Bewersdorf J, Zeidan A, Stahl M. Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS. Blood Reviews 2023, 60: 101056. PMID: 36805300, DOI: 10.1016/j.blre.2023.101056.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsMyelodysplastic syndromeDNA methyltransferase inhibitorLow risk (LR) MDSHigh-risk myelodysplastic syndromeHigh transfusion needsRisk myelodysplastic syndromesCurrent treatment landscapeErythropoiesis-stimulating agentsNovel drug developmentHR-MDSTreatment landscapeTransfusion needsTargetable mutationsClinical trialsMDS pathogenesisNew agentsRing sideroblastsMore drugsUnmet needTherapy developmentDrug developmentMethyltransferase inhibitorFactor mutationsApprovalInflammation
2021
Screening of blood donors for sickle cell trait using a DNA‐based approach: Frequency in a multiethnic donor population
Gowda L, Vege S, Kessler D, Shaz B, Westhoff CM. Screening of blood donors for sickle cell trait using a DNA‐based approach: Frequency in a multiethnic donor population. Transfusion 2021, 61: 2008-2013. PMID: 33929058, DOI: 10.1111/trf.16403.Peer-Reviewed Original ResearchConceptsSickle cell traitCell traitHigh-performance liquid chromatographyTesting of donorsSpecific patient groupsSickle cell diseaseHuman erythrocyte antigensTransfusion needsPatient groupBlood donorsCell diseaseRepeat testingRandom donorsScreen donorsGene sequencingDonor recordsErythrocyte antigensDonor populationHb screeningHemoglobin solubilityRBC donorsGold standardScreening resultsNegative resultsHemoglobin variation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply